Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.5253
Dollar change
+0.0040
Percentage change
0.77
%
Index- P/E- EPS (ttm)-1.45 Insider Own31.05% Shs Outstand10.40M Perf Week-11.28%
Market Cap5.76M Forward P/E- EPS next Y-1.35 Insider Trans0.30% Shs Float7.56M Perf Month-76.76%
Income-14.10M PEG- EPS next Q-0.21 Inst Own11.98% Short Float1.00% Perf Quarter-85.56%
Sales5.44M P/S1.06 EPS this Y9.77% Inst Trans-12.02% Short Ratio0.74 Perf Half Y-80.83%
Book/sh0.28 P/B1.89 EPS next Y-16.88% ROA- Short Interest0.08M Perf Year-83.11%
Cash/sh0.53 P/C0.98 EPS next 5Y- ROE- 52W Range0.49 - 5.39 Perf YTD-85.53%
Dividend Est.- P/FCF- EPS past 5Y64.46% ROI-463.78% 52W High-90.25% Beta0.56
Dividend TTM- Quick Ratio0.85 Sales past 5Y49.19% Gross Margin89.78% 52W Low7.20% ATR (14)0.16
Dividend Ex-Date- Current Ratio0.85 EPS Y/Y TTM93.06% Oper. Margin-288.92% RSI (14)22.59 Volatility24.10% 26.32%
Employees11 Debt/Eq0.46 Sales Y/Y TTM- Profit Margin-259.08% Recom1.00 Target Price10.75
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q88.23% Payout- Rel Volume1.37 Prev Close0.52
Sales Surprise0.00% EPS Surprise68.97% Sales Q/Q-100.00% EarningsMar 21 AMC Avg Volume101.62K Price0.53
SMA20-21.60% SMA50-71.15% SMA200-80.36% Trades Volume139,453 Change0.77%
Mar-21-24 10:54PM
04:02PM
Mar-12-24 08:00AM
Feb-29-24 09:36AM
08:30AM
08:30AM Loading…
Feb-22-24 08:30AM
Feb-14-24 08:30AM
Feb-07-24 08:30AM
Jan-17-24 08:30AM
Jan-04-24 08:30AM
Dec-15-23 08:35AM
Dec-13-23 08:30AM
Dec-12-23 01:02PM
09:24AM
Nov-28-23 08:30AM
08:30AM Loading…
Nov-09-23 08:30AM
Nov-06-23 08:30AM
Nov-03-23 04:07PM
04:01PM
04:00PM
Oct-17-23 08:30AM
Oct-12-23 10:19AM
07:20AM
Oct-09-23 12:10PM
Oct-05-23 04:09PM
Oct-04-23 08:30AM
08:00AM
Oct-03-23 08:30AM
Sep-28-23 09:30AM
Sep-25-23 09:30AM
09:30AM Loading…
Sep-18-23 09:30AM
Sep-16-23 09:00PM
Aug-31-23 09:30AM
Aug-16-23 06:44AM
Aug-11-23 04:07PM
04:01PM
Aug-04-23 06:23AM
Aug-03-23 08:03AM
Jul-26-23 01:30PM
Jun-29-23 06:30AM
Jun-28-23 06:30AM
Jun-20-23 05:50AM
May-24-23 06:30AM
May-23-23 06:30AM
May-11-23 05:39PM
05:20PM
Apr-24-23 04:01PM
Apr-20-23 08:38AM
Apr-17-23 06:30AM
Apr-12-23 06:30AM
Apr-03-23 06:30AM
Mar-31-23 04:01PM
Mar-22-23 06:30AM
Mar-08-23 06:30AM
Mar-06-23 06:30AM
Mar-01-23 06:30AM
Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Mercer Island, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bartoszek Raymond J.DirectorDec 06 '23Buy4.502501,12517,206Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 05 '23Buy4.501,0004,50016,956Dec 06 06:21 PM
Bartoszek Raymond J.DirectorDec 04 '23Buy4.331,0004,32515,956Dec 06 06:21 PM
Iadonato ShawnChief Executive OfficerNov 29 '23Buy3.514,10014,403675,230Nov 30 05:21 PM
PHILIPS CRAIG W.PresidentNov 28 '23Buy3.273,0009,81260,811Nov 30 05:27 PM
Iadonato ShawnChief Executive OfficerNov 28 '23Buy3.339002,995671,130Nov 30 05:21 PM
Foote Marion RDirectorOct 11 '23Option Exercise0.144,443622143,204Oct 12 04:25 PM
PHILIPS CRAIG W.PresidentSep 21 '23Buy2.402,9006,97057,811Sep 21 04:58 PM
Iadonato ShawnChief Executive OfficerSep 20 '23Buy2.5010,00025,042670,230Sep 21 04:57 PM
Kenny PaulineGeneral Counsel & SecretarySep 20 '23Buy2.581,5003,87018,448Sep 21 04:57 PM
PHILIPS CRAIG W.PresidentSep 20 '23Buy2.546001,52554,911Sep 21 04:58 PM
Bartoszek Raymond J.DirectorSep 19 '23Buy2.372,0004,74514,956Sep 21 04:56 PM
Baker KeithChief Financial OfficerSep 18 '23Buy2.135,00010,67216,880Sep 19 05:03 PM
Bartoszek Raymond J.DirectorSep 18 '23Buy2.082,5005,20012,956Sep 19 05:02 PM
Bartoszek Raymond J.DirectorSep 15 '23Buy2.185001,09010,456Sep 19 05:02 PM
Guillaudeux ThierryChief Scientific OfficerSep 14 '23Buy2.0010,00020,00021,696Sep 15 06:49 PM
Baker KeithChief Financial OfficerJun 16 '23Buy2.925,00014,60011,880Jun 16 04:28 PM
Bartoszek Raymond J.DirectorJun 14 '23Option Exercise0.1460,0188,403844,478Jun 16 04:29 PM
PHILIPS CRAIG W.PresidentJun 14 '23Option Exercise0.141,38219334,654Jun 16 04:31 PM
Iadonato ShawnChief Executive OfficerJun 14 '23Option Exercise0.141,382193667,669Jun 16 04:29 PM